1 / 35

EXTRAPYRAMIDAL SYSTEM and BASAL GANGLIA

EXTRAPYRAMIDAL SYSTEM and BASAL GANGLIA. Burcu Ormeci,MD Department of Neurology. Extrapyramidal System. 2 main system manage motor functions Pyramidal system Corticospinal tract Extrapyramidal system Basal ganglia caudate putamen globus pallidus.

Download Presentation

EXTRAPYRAMIDAL SYSTEM and BASAL GANGLIA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. EXTRAPYRAMIDAL SYSTEM andBASAL GANGLIA Burcu Ormeci,MD Department of Neurology

  2. Extrapyramidal System • 2 main system manage motor functions • Pyramidal system • Corticospinal tract • Extrapyramidal system • Basal ganglia • caudate • putamen • globus pallidus

  3. Neurotransmitters/Neuromodulators at Basal Ganglia • GABA  inhibitory • Glutamate  excitatory • Dopamine  • D1 receptors  excitatory • D2 receptors  inhibitory • Acetylcholine modulator • Not excitatory or inhibitory • It changes excitability

  4. Motor Functions of the Basal Ganglia • The initiation and planning of movements • Adjusting speed and magnitude of movement • Automatically implementation of learned motor programs (walking, cycling, etc.) • Implementation of consecutive or simultaneous movements • Adjustment of muscle tone • Truncal stability

  5. Classification of The Movement Disorders • Movementdisordersareclassifiedaccordingto dominant abnormalorinvoluntarymovements • hypokinetic (reducedmovement) • hyperkinetic (increasedmovement)

  6. HYPOKINETIC MOVEMENT DISORDERS

  7. HypokineticMovementDisorders • It is named «Akinetic-rigid syndromes» • Parkinson's syndrome is prototype of Akinetic-rigid syndromes

  8. Parkinson’s Syndrom • Symptoms • Bradykinesia-akinesia • Rigidity • Postural instability • Resting tremor • may be accompanied, but it is not necessary

  9. Parkinson’s Syndrom DEGENERATİVE 1 - Idiopathic Parkinson's disease (IPD) 2 - Parkinson's plus syndromes multisystem atrophy, Progressive supranuclear palsy corticobasal degeneration, Lewy Body Dementia 3 - Parkinsonism associated other degenerative diseases Spinocerebellar ataxia type 2,3,17 Huntington's Disease Striapallidodentat bilateral calcinosis (Fahr's Disease) Frontotemporal dementia-parkinsonism complex Dentatorubropallidolusian atrophy Nöroakantositoz ect Underlying pathology of these diseases are degenerative cell loss and not be detected in another reason

  10. Parkinson’s Syndrom Symptomatic 1 - Vascular (small vessel disease-related subcortical encephalopathy, multiple lacunar infarcts, basal ganglia and Brainstem hemorrhages and infarcts) 2 - Normal pressure hydrocephalus 3 - Tumors 4 - Drug-induced (neuroleptics, dopamine exhausting drugs, calcium channel blockers, antiemetics, valproic acid, lithium) 5 - Intoxications (carbon monoxide, manganese, potassium permanganate, ephedrine abuse, mercury and other heavy metals, organic solvents, paint thinner, carbon disulfide, MPTP, cyanide) 6 - Infections (encephalitis, prion disease, neurosyphilis, toxoplasmosis) 7 - Metabolic causes (hypoxia, hypoparathyroidism, extra-pontine miyelinozis, chronic liver disease, Wilson's disease) 8 - Head injury, dementia pugilistica (boxer) 9 - Demyelinating Diseases 10 - Psychogenic Parkinsonism

  11. IDIOPATIC PARKINSON’S DISEASE • Constitutes 80-85% of parkinsonism • Theaverageage of onset is 50-60 years • Early-onset <40 years • Juvenile <20 years • Loss of dopaminergiccellsin thesubstantianigra pars compacta • Lewybodies • Whendopaminergiccelllossreachto 60-70%, clinicalsymptoms start tooccur

  12. IDIOPATIC PARKINSON’S DISEASE • Thecardinalsymptoms of Parkinson'sdisease • Bradykinesia + • Rigidity • Resting tremor • Posturalinstability *Not needto be all-in-one *Thediseaseoftenbeginsfromhalf of the body asymmetrically

  13. IDIOPATIC PARKINSON’S DISEASE • Otherclinicalsymptoms of Parkinson'sdisease • Anteflexionposture • Freezingphenomenon • Gaitdisorders • Speech disorders • Micrography, dysphagia • Autonomicdisorders • Mental-emotionalsymptoms • Sleepdisorders • Odorandvisualperceptiondisorders

  14. IDIOPATIC PARKINSON’S DISEASE • Resting Tremor • Often, the first clinical finding is motor symptoms, 15% never seen • Frequency is 4-6 Hz • Usually emerges on the hands, sometimes on the feet, tongue, jaw and lip • Audio and head tremor never emerges • Increases with stress, mental activity and walking

  15. IDIOPATIC PARKINSON’S DISEASE • Bradykinesia / Akinesia • The most characteristic symptom of basal ganglia disorders • Presence is necessary to diagnosis • Bradimimi, micrography, decrease of associate movements and sialorrhoea develop because of this symptom • The most basic symptom of disability

  16. IDIOPATIC PARKINSON’S DISEASE • Rigidity • Due to agonist and antagonist muscles have increased tone simultaneously • Called cogwheel phenomenon • Emerges by passive motion • Increases with other extremity motion (Froment's sign) • Patients describe as stiffness or hardness

  17. IDIOPATIC PARKINSON’S DISEASE • Postural instability • The most common cause of disability • Occurs in later stages of the disease • Due to loss of postural reflex • The most common cause of falls • Pull test is used for diagnosis • Patients fall down while sitting as a block

  18. TREATMENT ofPARKINSON’S DISEASE • Dopaminergicdrugs • Levodopa (dopamine precursor) • Dopamineagonists • Thesedrugsmimictheeffect of dopamineas bindingtodopaminereceptors • Anticholinergicagents • Re-providedeterioratedbalancebetweendopamineandacetylcholine in thebasalganglia • MAO-B inhibitors • Main enzymewhichdestroyedthedopamine • Dopaminestays in thesynapticgapforlongertime • COMT inhibitors • Amantadine (PK-Mertz)

  19. PARKINSON’S DISEASETREATMENT • SURGICAL • Destruction of problematic areas • Stereotactic surgery • Gamma-knife • Deep brain stimulation • High-frequency electrical impulses via deep electrodes reduce the activity of the cells in problematic areas

  20. PARKINSON PLUS SYNDROMS • Common features • Classic signs of Parkinson's syndrome (bradykinesia, rigidity, tremor, postural reflex abnormalities)+ • Additional signs and symptoms

  21. HYPERKINETIC MOVEMENT DISORDERS

  22. DYSTONIA • Characterizedbyinvoluntary, continuous, twisting, rotatingmusclecontraction • Recurrent • Resultswithtemporaryorpermanentabnormalpostures • Disappearsduringsleep • Dystoniccontractionstemporarilylosswithtouch • Sensorytrick

  23. Type of Dystonias • HemifasyalSpasm • Only on half of theface • May be continuousorintermittent • Semi-rhythmiccontractions • Blepharospasm • Increasing of eyeblinkfrequencyfunctionalblindness • OromandibulolingualDystonia • Dystoniaaroundthemouth-jaw-tongue • LaryngealDystonia (pasmodicDysphonia) • Difficulty of voicingandspeech

  24. Type of Dystonias • Cervical Dystonia (spasmodic torticollis) • Torticollis • Laterocollis • Anterocollis • Retrocollis • "Task Specific” dystonia • Occurs only during selective motor functions • The most common is "writer's cramp"

  25. CHOREA and BALLISM • Arrhythmic, rapid, saltatory or smooth, simple or complex movements • Chorea • Amplitude is smaller • Usually seen in distal of extremity • Ballism • Amplitude is greater • Usually seen in proximal of extremity

  26. TREMOR • Tremor, • is involuntary, rhythmicoscillations • occur as a result of synchronouscontraction of thereciprocalmuscles 1- Kinetic tremor - Intensiyenel tremor (cerebellum) 2- Postural Tremor 3-Resting tremor

  27. Tremor Physiological tremor • 10-12 hz, postural tremor withlow-amplitude • Etiology • Mentalreasons (anxiety, stress, fatigue), • Metaboliccauses ( fever, thyrotoxicosis, hypoglycaemia, ect.), • Drugs (neuroleptics, beta-adrenergicagonists, valproicacid, lithium, steroids, dopamineagonists, antidepressants), • Toxins (mercury, lead, arsenic) • Somefoodingredients (caffeine) May leadtoincreasedphysiological tremor

  28. MYOCLONUS • Sudden, short-term (<100ms), as fast as lightning • Form of throwing, jumping • Positive myoclonus • The sudden contraction of a particular muscle group • Negative myoclonus (asterixis) • Sudden relaxation of the muscles while maintain a posture

  29. MYOCLONUS • Physiologicalmyoclonus • Whilefallingasleep, afterexcessiveexercise , in anxiety • Essentialmyoclonus • There is nopathologicalsignsandsymptomsrelatedtoanotherdisorders • ReducethesymptomswithAlcohol is typically • Symptomaticmyoclonus • Duringthecourse of diseasessuch as Liverfailure, uremia, electrolyteimbalance, poisoning, headtrauma, hypoxic-ischemicensafalopati (Lance-Adams syndrome), neurodegenerativediseases, centralnervoussysteminfections, priondiseases… etc

  30. Sleep-related Movement Disorders • Restless Legs Syndrome • It is identified leg discomfort at rest or before sleep • Periodic limb movements of sleep • Semirhythmic involuntary movements during sleep especially in the feet

  31. Drug-related Movement Disorders • Acute Dystonic Reactions • Within a few hours after drug intake • Especially around the head, neck, face, tongue and mouth • Form of dyskinetic and dystonic involuntary movements • SubacuteParkinsonism or Akathisia • Neuroleptic useingforlast 1-3 months • Usually reversible • Tardive Syndromes • As a result of long-term use of neuroleptic • Sometime irreversible

  32. PSYCHOGENIC MOVEMENT DISORDERS • Can mimic all kinds of movement disorders such as dystonia, myoclonus, tremor, tic disorder • Symptoms onset suddenly • Emerge after psychic trauma • There is serious handicaps • It is bizaare, doesn’tlike normal forms • If the patient's attention is disrupted, symptoms ameliorate • There are some periods of self-recovery • Positive response to placebo treatment • The presence of secondary gain • Neurological examination is completely normal • The presence of symptoms that suggestive psychopathology

  33. Treatment of Hyperkinetic Movement Disorders • Treatment is symptomatic • Anticholinergics • Antidopaminergics (neuroleptics) • Baclofen • Benzodiazepines • Botulinum toxin

More Related